| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |